Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties

scientific article published on November 1, 1992

Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties is …

instance of (P31):

scholarly article

External links are

PubMed publication ID

P2093	author name string	R. Koch
		R. Jackisch
		B. Neufang
		T. Link
P407	language of work or name	English	Q1860
P304	page(s)	21-42
P577	publication date	1992-11-01
P1433	published in	Archives Internationales De Pharmacodynamie Et De Therapie	Q9430698
P1476	title	Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties
P478	volume	320

Reverse relations

cites work (P2860)

Q72061434	Amantadine stimulates sexual behavior in male rats
Q37008274	Distribution and dynamics of adamantanes in a lipid bilayer
Q41172466	Early detection of Parkinson's disease. Implications for treatment
Q46890768	Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia
Q64968139	Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia
Q57780603	Memantine fails to facilitate partial cigarette deprivation in smokers – no role of Memantine in the treatment of nicotine dependency?
Q72142546	Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats
Q37188990	Pathological laughing and crying : epidemiology, pathophysiology and treatment
Q30566749	Tardive dyskinesia: therapeutic options for an increasingly common disorder
Q34268122	The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease